arrow
返回

Know your target, know your molecule

delete2015-05-15
delete92
PRE
AI
M
Mark E. Bunnage *
A
A. Gilbert
L
Lyn H. Jones
E
Erik C. Hett
DOI:10.1038/nchembio.1813delete
delete原文链接
delete原文求助
delete分享
delete收藏
摘要

摘要

En 中文
The pharmaceutical industry continues to experience significant attrition of drug candidates during phase 2 proof-of-concept clinical studies. We describe some questions about the characteristics of protein targets and small-molecule drugs that may be important to consider in drug-discovery projects and could improve prospects for future clinical success.
Keyword:
INHIBITORS
SELECTIVITY
DISCOVERY
BIOLOGY
GROWTH
POTENT
PROBES
AI总结

AI总结

对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

Nature Chemical Biology 封面图
Nature Chemical Biology
IF:
13.7
论文数:
4.8K
被引数:
3.3W

机构

P
Pfizer
学者数:
2.3W
论文数: 1.2W
被引数: 22
引用论文

引用论文

CHIMERA: A 0.92-TOPS, 2.2-TOPS/W Edge AI Accelerator With 2-MByte On-Chip Foundry Resistive RAM for Efficient Training and Inference
err2022-04-01
err0
errOAAI
errKartik Prabhu; Albert Gural; Zainab F. Khan; Robert M. Radway; Massimo Giordano; Kalhan Koul; Rohan Doshi; John W. Kustin; Timothy Liu; Gregorio B. Lopes; Victor Turbiner; Win-San Khwa; Yu-Der Chih; Meng-Fan Chang; Guenole Lallement; Boris Murmann; Subhasish Mitra; Priyanka Raina
err分享
err收藏
ATP-Mediated Kinome Selectivity: The Missing Link in Understanding the Contribution of Individual JAK Kinase Isoforms to Cellular Signaling
err2014-05-28
err56
PREAI
errThorarensen, Atli; Banker, Mary Ellen; Fensome, Andrew; Telliez, Jean-Baptiste; Juba, Brian; Vincent, Fabien; Czerwinski, Robert M.; Casimiro-Garcia, Agustin
err分享
err收藏
Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Noninflammatory Pain
err2011-07-01
err210
errOAAI
errAhn, Kay; Smith, Sarah E.; Liimatta, Marya B.; Beidler, David; Sadagopan, Nalini; Dudley, David T.; Young, Tim; Wren, Paul; Zhang, Yanhua; Swaney, Steven; Van Becelaere, Keri; Blankman, Jacqueline L.; Nomura, Daniel K.; Bhattachar, Shobha N.; Stiff, Cory; Nomanbhoy, Tyzoon K.; Weerapana, Eranthie; Johnson, Douglas S.; Cravatt, Benjamin F.
err分享
err收藏
Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival
err2012-05-01
err543
PREAI
errMorgan, Paul; Van der Graaf, Piet H.; Arrowsmith, John; Feltner, Doug E.; Drummond, Kira S.; Wegner, Craig D.; Street, Steve D. A.
err分享
err收藏
The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity
err2014-07-27
err142
errOAAI
errWinter, Georg E.; Radic, Branka; Mayor-Ruiz, Cristina; Blomen, Vincent A.; Trefzer, Claudia; Kandasamy, Richard K.; Huber, Kilian V. M.; Gridling, Manuela; Chen, Doris; Klampfl, Thorsten; Kralovics, Robert; Kubicek, Stefan; Fernandez-Capetillo, Oscar; Brummelkamp, Thijn R.; Superti-Furga, Giulio
err分享
err收藏
A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors
err2014-07-13
err302
errOAAI
errLannine, Bryan R.; Whitby, Landon R.; Dix, Melissa M.; Douhan, John; Gilbert, Adam M.; Hett, Erik C.; Johnson, Theodore; Joslynl, Chris; Kath, John C.; Niessen, Sherry; Roberts, Lee R.; Schnute, Mark E.; Wang, Chu; Hulce, Jonathan J.; Wei, Baoxian; Whiteley, Laurence O.; Hayward, Matthew M.; Cravatt, Benjamin F.
err分享
err收藏
Preclinical target validation using patient-derived cells使用患者来源的细胞进行临床前目标验证
err2015-02-20
err45
PREAI
errEdwards, Aled M.; Arrowsmith, Cheryl H.; Bountra, Chas; Bunnage, Mark E.; Feldmann, Marc; Knight, Julian C.; Patel, Dhavalkumar D.; Prinos, Panagiotis; Taylor, Michael D.; Sundstrom, Michael
err分享
err收藏
Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance
err2013-12-17
err237
errOAAI
errSchwartz, Phillip A.; Kuzmic, Petr; Solowiej, James; Bergqvist, Simon; Bolanos, Ben; Almaden, Chau; Nagata, Asako; Ryan, Kevin; Feng, Junli; Dalvie, Deepak; Kath, John C.; Xu, Meirong; Wani, Revati; Murray, Brion William
err分享
err收藏
学者 查看更多内容